Wednesday - September 2, 2026
Goodwin Advises Mission BioCapital on Securing Eligibility for $44.5 Million Non-Dilutive Funding Through AMED Program
September 02, 2026
BOSTON, Massachusetts, Sept. 2 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:

* * *

Goodwin Advises Mission BioCapital on Securing Eligibility for $44.5 Million Non-Dilutive Funding Through AMED Program

*

Goodwin's Life Sciences and Private Equity teams advised Mission BioCapital (MBC) on its successful application to participate in the Japan Agency for Medical Research and Development (AMED) Drug Disco . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products